...
首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Rhus coriaria ameliorates insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM) rats
【24h】

Rhus coriaria ameliorates insulin resistance in non-insulin-dependent diabetes mellitus (NIDDM) rats

机译:鼠李氏菌改善非胰岛素依赖型糖尿病(NIDDM)大鼠的胰岛素抵抗

获取原文
获取原文并翻译 | 示例
           

摘要

We have investigated the effect of methanolic extract of Rhus coriaria (RC) on hyperinsulinemia, glucose intolerance and insulin sensitivity in non-insulin-dependent diabetes mellitus (NIDDM) rats. NIDDM was induced by single intraperitoneal injection of streptozotocin (STZ, 100 mg/kg) to 2 days old rat pups. RC (200 mg/kg and 400 mg/kg) was administered orally once a day for 5 weeks after the animals were confirmed diabetic (i.e, 90 days after STZ injection). A group of citrate control rats were also maintained which has received citrate buffer on the 2nd day of their birth. There was a significant increase in blood glucose, glycosylated hemoglobin (HbA 1c) and serum insulin levels were observed in NIDDM control rats. Treatment with RC reduced the elevated levels of blood glucose, HbA1c and insulin in the NIDDM rats. An oral glucose tolerance test (OGTT) was also performed in the same groups, in which we found a significant improvement in glucose tolerance in the rats treated with RC. The insulin sensitivity was assessed for both peripheral insulin resistance and hepatic insulin resistance. RC treatment significantly improved insulin sensitivity index (KITT) which was significantly decreased in NIDDM control rats. There was significant rise in homeostasis model assessment of insulin resistance (HOMA-R) in NIDDM control rats whereas RC treatment significantly prevented the rise in HOMA-R in NIDDM treated rats. Our data suggest that methanolic extract of RC significantly delayed the onset of hyperinsulinemia and glucose intolerance and improved insulin sensitivity in NIDDM rats.
机译:我们已经研究了在非胰岛素依赖型糖尿病(NIDDM)大鼠中高脂血症(RC)的甲醇提取物对高胰岛素血症,葡萄糖耐量和胰岛素敏感性的影响。通过腹膜内注射链脲佐菌素(STZ,100 mg / kg)至2天大的幼鼠来诱导NIDDM。在确定动物患有糖尿病后(即STZ注射后90天),连续5周每天一次口服RC(200 mg / kg和400 mg / kg)。还维持一组柠檬酸盐对照大鼠,它们在出生的第二天接受了柠檬酸盐缓冲液。在NIDDM对照大鼠中观察到血糖,糖基化血红蛋白(HbA 1c)和血清胰岛素水平显着增加。 RC治疗可降低NIDDM大鼠的血糖,HbA1c和胰岛素水平升高。在相同的组中还进行了口服葡萄糖耐量试验(OGTT),在其中我们发现用RC治疗的大鼠的葡萄糖耐量显着改善。对于外周胰岛素抵抗和肝胰岛素抵抗都评估了胰岛素敏感性。 RC治疗显着改善了胰岛素敏感性指数(KITT),而在NIDDM对照大鼠中胰岛素敏感性指数显着降低。 NIDDM对照大鼠的胰岛素抵抗(HOMA-R)稳态模型评估显着增加,而RC治疗则显着阻止了NIDDM治疗大鼠的HOMA-R升高。我们的数据表明,RC的甲醇提取物可显着延迟NIDDM大鼠的高胰岛素血症和葡萄糖耐受不良的发作,并改善胰岛素敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号